Michael Baker

Michael Baker serves as Chief Executive Officer and Managing Director at Arovella Therapeutics ASX: ALA. Arovella Therapeutics ASX: ALA operates in the research sector with approximately 19.0 employees. The company is headquartered in Melbourne, Victoria. Arovella Therapeutics ASX: ALA generates annual revenue of 268000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at Arovella Therapeutics ASX: ALA.
• • 2,608 executive contacts are available in Victoria.
• • Our database includes 201,465 c suite-level executives.

Outlook Mobile Friendly Vimeo Google Tag Manager WordPress.org YouTube Squarespace ECommerce Basis

biotechnology advanced cell therapy oncology inkt cell therapy invariant natural killer t cell therapy platform car engineering blood cancers solid tumours biotechnology research inkt cells car-inkt therapy cd19 targeting solid tumour treatment blood cancer therapy allogeneic cell therapy off-the-shelf car therapy cldn18.2 targeting cytokine technology il-12-tm tumour microenvironment immune cell therapy chimeric antigen receptor cancer immunotherapy multi-targeting therapy tumour angiogenesis immune system modulation personalized medicine cellular therapeutics therapeutic development pharmaceutical innovation cancer treatment haematological cancer cancer vaccines cell engineering preclinical studies antigen recognition tumour-associated antigens cancer cell destruction adaptive immune response vector technology drug development clinical trials patient-centric approach biopharmaceuticals cancer research therapeutic platforms cytokine release syndrome t cell activation tumour immunity cd1d recognition nkg2d pathway cancer strategies pro-tumour cells monoclonal antibody development patient access healthcare innovation hospital & health care health care health wellness & fitness

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Michael Baker in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Arovella Therapeutics ASX: ALA.

Michael Baker's Position in the MessageCEO Database

• •2,871 verified executive contacts in research are in the MessageCEO database.
• •2,562 verified executive contacts in Victoria are in the database.
• •10 verified contacts work at research companies in the 19.0 employee range (same size as Arovella Therapeutics ASX: ALA).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated October 2026.

How do I reach Michael Baker directly?

Michael Baker's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer and Managing Director at Arovella Therapeutics ASX: ALA. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Michael Baker work for?

Michael Baker is Chief Executive Officer and Managing Director at Arovella Therapeutics ASX: ALA, a company in the research sector with 19.0 employees. The company is based in Melbourne, Victoria.

Can I pitch or sell to Michael Baker?

As Chief Executive Officer and Managing Director at Arovella Therapeutics ASX: ALA, Michael Baker is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Michael Baker directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Michael Baker in?

Michael Baker works in the research industry as Chief Executive Officer and Managing Director at Arovella Therapeutics ASX: ALA. MessageCEO provides verified contact information for executives across all major industries.

Is Michael Baker's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Michael Baker's profile is kept up-to-date with the latest available information.

Last updated: October 15, 2026